196 related articles for article (PubMed ID: 15979264)
1. Excipient effects on gastrointestinal transit and drug absorption in beagle dogs.
Schulze JD; Peters EE; Vickers AW; Staton JS; Coffin MD; Parsons GE; Basit AW
Int J Pharm; 2005 Aug; 300(1-2):67-75. PubMed ID: 15979264
[TBL] [Abstract][Full Text] [Related]
2. Impact of formulation excipients on human intestinal transit.
Schulze JD; Ashiru DA; Khela MK; Evans DF; Patel R; Parsons GE; Coffin MD; Basit AW
J Pharm Pharmacol; 2006 Jun; 58(6):821-5. PubMed ID: 16734983
[TBL] [Abstract][Full Text] [Related]
3. The effect of polyethylene glycol 400 on gastrointestinal transit: implications for the formulation of poorly-water soluble drugs.
Basit AW; Newton JM; Short MD; Waddington WA; Ell PJ; Lacey LF
Pharm Res; 2001 Aug; 18(8):1146-50. PubMed ID: 11587486
[TBL] [Abstract][Full Text] [Related]
4. Concentration-dependent effects of polyethylene glycol 400 on gastrointestinal transit and drug absorption.
Schulze JD; Waddington WA; Eli PJ; Parsons GE; Coffin MD; Basit AW
Pharm Res; 2003 Dec; 20(12):1984-8. PubMed ID: 14725363
[TBL] [Abstract][Full Text] [Related]
5. Influence of polyethylene glycol 400 on the gastrointestinal absorption of ranitidine.
Basit AW; Podczeck F; Newton JM; Waddington WA; Ell PJ; Lacey LF
Pharm Res; 2002 Sep; 19(9):1368-74. PubMed ID: 12403075
[TBL] [Abstract][Full Text] [Related]
6. Enhanced intestinal absorption of vancomycin with Labrasol and D-alpha-tocopheryl PEG 1000 succinate in rats.
Prasad YV; Puthli SP; Eaimtrakarn S; Ishida M; Yoshikawa Y; Shibata N; Takada K
Int J Pharm; 2003 Jan; 250(1):181-90. PubMed ID: 12480284
[TBL] [Abstract][Full Text] [Related]
7. Excipient-mediated alteration in drug bioavailability in the rat depends on the sex of the animal.
Mai Y; Afonso-Pereira F; Murdan S; Basit AW
Eur J Pharm Sci; 2017 Sep; 107():249-255. PubMed ID: 28709912
[TBL] [Abstract][Full Text] [Related]
8. A comparison of intestinal lymphatic transport and systemic bioavailability of saquinavir from three lipid-based formulations in the anaesthetised rat model.
Griffin BT; O'Driscoll CM
J Pharm Pharmacol; 2006 Jul; 58(7):917-25. PubMed ID: 16805951
[TBL] [Abstract][Full Text] [Related]
9. Absorption barriers in the rat intestinal mucosa. 3: Effects of polyethoxylated solubilizing agents on drug permeation and metabolism.
Mudra DR; Borchardt RT
J Pharm Sci; 2010 Feb; 99(2):1016-27. PubMed ID: 19650119
[TBL] [Abstract][Full Text] [Related]
10. Improvement of the bioavailability of colchicine in rats by co-administration of D-alpha-tocopherol polyethylene glycol 1000 succinate and a polyethoxylated derivative of 12-hydroxy-stearic acid.
Bittner B; Guenzi A; Fullhardt P; Zuercher G; González RC; Mountfield RJ
Arzneimittelforschung; 2002; 52(9):684-8. PubMed ID: 12404883
[TBL] [Abstract][Full Text] [Related]
11. The effects of pharmaceutical excipients on small intestinal transit.
Adkin DA; Davis SS; Sparrow RA; Huckle PD; Phillips AJ; Wilding IR
Br J Clin Pharmacol; 1995 Apr; 39(4):381-7. PubMed ID: 7640144
[TBL] [Abstract][Full Text] [Related]
12. Effects of Labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine123, a P-glycoprotein substrate, in rats.
Lin Y; Shen Q; Katsumi H; Okada N; Fujita T; Jiang X; Yamamoto A
Biol Pharm Bull; 2007 Jul; 30(7):1301-7. PubMed ID: 17603171
[TBL] [Abstract][Full Text] [Related]
13. Effect of a lipoidic excipient on the absorption profile of compound UK 81252 in dogs after oral administration.
Chang RK; Shojaei AH
J Pharm Pharm Sci; 2004 Jan; 7(1):8-12. PubMed ID: 15144729
[TBL] [Abstract][Full Text] [Related]
14. An in vitro examination of the impact of polyethylene glycol 400, Pluronic P85, and vitamin E d-alpha-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine.
Johnson BM; Charman WN; Porter CJ
AAPS PharmSci; 2002; 4(4):E40. PubMed ID: 12646011
[TBL] [Abstract][Full Text] [Related]
15. P-glycoprotein and surfactants: effect on intestinal talinolol absorption.
Bogman K; Zysset Y; Degen L; Hopfgartner G; Gutmann H; Alsenz J; Drewe J
Clin Pharmacol Ther; 2005 Jan; 77(1):24-32. PubMed ID: 15637528
[TBL] [Abstract][Full Text] [Related]
16. An animal's sex influences the effects of the excipient PEG 400 on the intestinal P-gp protein and mRNA levels, which has implications for oral drug absorption.
Mai Y; Dou L; Murdan S; Basit AW
Eur J Pharm Sci; 2018 Jul; 120():53-60. PubMed ID: 29678614
[TBL] [Abstract][Full Text] [Related]
17. Polyethylene glycol 400 enhances the bioavailability of a BCS class III drug (ranitidine) in male subjects but not females.
Ashiru DA; Patel R; Basit AW
Pharm Res; 2008 Oct; 25(10):2327-33. PubMed ID: 18600434
[TBL] [Abstract][Full Text] [Related]
18. Novel powder formulations for controlled delivery of poorly soluble anticancer drug: application and investigation of TPGS and PEG in spray-dried particulate system.
Mu L; Teo MM; Ning HZ; Tan CS; Feng SS
J Control Release; 2005 Apr; 103(3):565-75. PubMed ID: 15820404
[TBL] [Abstract][Full Text] [Related]
19. Small doses of the unabsorbable substance polyethylene glycol 3350 accelerate oro-caecal transit, but slow gastric emptying in healthy subjects.
Coremans G; Vos R; Margaritis V; Ghoos Y; Janssens J
Dig Liver Dis; 2005 Feb; 37(2):97-101. PubMed ID: 15733521
[TBL] [Abstract][Full Text] [Related]
20. Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo.
Varma MV; Panchagnula R
Eur J Pharm Sci; 2005; 25(4-5):445-53. PubMed ID: 15890503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
